These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1094 related articles for article (PubMed ID: 19736995)
1. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery. Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995 [TBL] [Abstract][Full Text] [Related]
2. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143 [TBL] [Abstract][Full Text] [Related]
3. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660 [TBL] [Abstract][Full Text] [Related]
4. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel. Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers. Yang Y; Hua C; Dong CM Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927 [TBL] [Abstract][Full Text] [Related]
6. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles. Gou M; Shi H; Guo G; Men K; Zhang J; Zheng L; Li Z; Luo F; Qian Z; Zhao X; Wei Y Nanotechnology; 2011 Mar; 22(9):095102. PubMed ID: 21270494 [TBL] [Abstract][Full Text] [Related]
7. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel. Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675 [TBL] [Abstract][Full Text] [Related]
8. One-step preparation of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticles for plasmid DNA delivery. Huang MJ; Gou ML; Qian ZY; Dai M; Li XY; Cao M; Wang K; Zhao J; Yang JL; Lu Y; Tu MJ; Wei YQ J Biomed Mater Res A; 2008 Sep; 86(4):979-86. PubMed ID: 18067161 [TBL] [Abstract][Full Text] [Related]
9. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer. Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659 [TBL] [Abstract][Full Text] [Related]
11. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties. Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912 [TBL] [Abstract][Full Text] [Related]
12. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer. Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556 [TBL] [Abstract][Full Text] [Related]
13. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin. Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Sun H; Guo B; Cheng R; Meng F; Liu H; Zhong Z Biomaterials; 2009 Oct; 30(31):6358-66. PubMed ID: 19666191 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery. Wang T; Li M; Gao H; Wu Y J Colloid Interface Sci; 2011 Jan; 353(1):107-15. PubMed ID: 20947092 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Wei X; Gong C; Gou M; Fu S; Guo Q; Shi S; Luo F; Guo G; Qiu L; Qian Z Int J Pharm; 2009 Oct; 381(1):1-18. PubMed ID: 19664700 [TBL] [Abstract][Full Text] [Related]
17. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection. Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279 [TBL] [Abstract][Full Text] [Related]
19. Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro. Zhang J; Men K; Gu Y; Wang X; Gou M; Guo G; Luo F; Qian Z J Nanosci Nanotechnol; 2011 Jun; 11(6):5054-61. PubMed ID: 21770143 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma. Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]